• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

管理式医疗是否会影响精神类药物的推广?

Does managed care affect the diffusion of psychotropic medications?

机构信息

The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7411, USA.

出版信息

Health Econ. 2012 Apr;21(4):428-43. doi: 10.1002/hec.1723. Epub 2011 Mar 7.

DOI:10.1002/hec.1723
PMID:21384465
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3138820/
Abstract

Newer technologies to treat many mental illnesses have shown substantial heterogeneity in diffusion rates across states. In this paper, I investigate whether variation in the level of managed care penetration is associated with changes in state-level diffusion of three newer classes of psychotropic medications in fee-for-service Medicaid programs from 1991 to 2005. Three different types of managed care programs are examined: capitated managed care, any type of managed care and behavioral health carve-outs. A fourth-order polynomial fixed effect regression model is used to model the diffusion path of newer antidepressant and antipsychotic medications controlling for time-varying state characteristics. Substantial differences are found in the diffusion paths by the degree of managed care use in each state Medicaid program. The largest effect is seen through spillover effects of capitated managed care programs; states with greater capitated managed care have greater initial shares of newer psychotropic medications. The influence of carve-outs and of all types of managed care combined on the diffusion path was modest.

摘要

治疗许多精神疾病的新技术在各州的传播率方面表现出显著的异质性。在本文中,我调查了在从 1991 年到 2005 年的以服务为基础的医疗补助计划中,三种新型精神药物在州一级的传播中,管理式医疗渗透率的变化是否与以下情况有关:全民医疗照顾计划中不同类型的管理式医疗计划:有条件付款制管理式医疗、任何类型的管理式医疗和行为健康专项拨款。使用四阶多项式固定效应回归模型,在控制各州随时间变化的特征的情况下,对新型抗抑郁药和抗精神病药物的传播路径进行建模。在每个州的医疗补助计划中,管理式医疗使用程度的不同导致了传播路径的显著差异。通过有条件付款制管理式医疗计划的溢出效应,可以看到最大的影响;有更多有条件付款制管理式医疗的州有更大份额的新型精神药物。专项拨款和所有类型的管理式医疗综合对传播路径的影响是适度的。

相似文献

1
Does managed care affect the diffusion of psychotropic medications?管理式医疗是否会影响精神类药物的推广?
Health Econ. 2012 Apr;21(4):428-43. doi: 10.1002/hec.1723. Epub 2011 Mar 7.
2
Substitution in a Medicaid mental health carve-out: services and costs.医疗补助计划中精神健康专项承保的替代方案:服务与成本
J Health Care Finance. 2002 Summer;28(4):11-23.
3
Association of Medicaid Managed Care Drug Carve Outs With Hepatitis C Virus Prescription Use.医疗补助管理式医疗药品除外计划与丙型肝炎病毒处方使用的关联。
JAMA Health Forum. 2021 Aug 27;2(8):e212285. doi: 10.1001/jamahealthforum.2021.2285. eCollection 2021 Aug.
4
Substance use disorder treatment carve outs in Medicaid managed care.医疗补助管理式医疗中物质使用障碍治疗的除外条款。
J Subst Use Addict Treat. 2024 Jun;161:209357. doi: 10.1016/j.josat.2024.209357. Epub 2024 Mar 28.
5
Spillover effects of benefit expansions and carve-outs on psychotropic medication use and costs.福利扩张和分拆对精神药物使用及成本的溢出效应。
Inquiry. 2005 Spring;42(1):86-97. doi: 10.5034/inquiryjrnl_42.1.86.
6
The evolution of an innovation: variations in medicaid managed care program extensiveness.创新的演变:医疗补助管理式医疗计划覆盖范围的变化。
J Health Polit Policy Law. 2012 Oct;37(5):815-49. doi: 10.1215/03616878-1672727. Epub 2012 Jun 14.
7
Medicaid managed care and the unmet need for mental health care among children with special health care needs.医疗补助管理式医疗与有特殊医疗需求儿童未得到满足的心理健康护理需求
Health Serv Res. 2008 Jun;43(3):882-900. doi: 10.1111/j.1475-6773.2007.00811.x.
8
Use of behavioral health care in Medicaid managed care carve-out versus carve-in arrangements.医疗补助管理式医疗中行为健康护理的使用:在分出式与划入式安排下的对比。
Health Serv Res. 2021 Oct;56(5):805-816. doi: 10.1111/1475-6773.13703. Epub 2021 Jul 26.
9
Physician Care Coordination and the Use of Psychotropic Polypharmacy in the Management of Pediatric Mental Disorders.医师医疗协调与精神科药物的广泛使用在儿科精神障碍管理中的应用。
J Manag Care Spec Pharm. 2019 Jan;25(1):29-38. doi: 10.18553/jmcp.2019.25.1.029.
10
The implementation of managed behavioral healthcare in Colorado and the effects on older Medicaid beneficiaries.科罗拉多州管理式行为医疗保健的实施及其对老年医疗补助受益人的影响。
J Ment Health Policy Econ. 2006 Mar;9(1):15-24.

引用本文的文献

1
Comparing Adoption of Breakthrough and "Me-too" Drugs among Medicare Beneficiaries: A Case Study of Dipeptidyl Peptidase-4 Inhibitors.比较医疗保险受益人中突破性药物和“me-too”药物的采用情况:二肽基肽酶-4抑制剂的案例研究
J Pharm Innov. 2017 Jun;12(2):105-109. doi: 10.1007/s12247-017-9277-x. Epub 2017 Feb 13.
2
State Investments in Psychiatric Innovation: Investigating Unmeasured State Factors.国家对精神科创新的投资:探究未衡量的国家因素。
Health Serv Outcomes Res Methodol. 2014 Jun 1;14(1-2):34-53. doi: 10.1007/s10742-014-0116-y.
3
Public managed care and service access in outpatient substance abuse treatment units.

本文引用的文献

1
First trend analysis of antifungals consumption in Lebanon using the World Health Organization collaborating center for drug statistics methodology.首次使用世界卫生组织合作中心药物统计方法学对黎巴嫩抗真菌药物的消费情况进行趋势分析。
BMC Infect Dis. 2022 Nov 24;22(1):882. doi: 10.1186/s12879-022-07883-5.
2
Socioeconomic Differences in the Adoption of New Medical Technologies.新医疗技术采用过程中的社会经济差异。
Am Econ Rev. 2005 May;95(2):234-7. doi: 10.1257/000282805774669907.
3
Technology Diffusion and Productivity Growth in Health Care.
门诊药物滥用治疗机构中的公共管理式医疗与服务可及性
J Behav Health Serv Res. 2011 Oct;38(4):444-63. doi: 10.1007/s11414-010-9230-y.
医疗保健领域的技术扩散与生产率增长
Rev Econ Stat. 2015 Dec;97(5):951-964. doi: 10.1162/REST_a_00535. Epub 2015 Dec 8.
4
What explains the diffusion of treatments for mental illness?如何解释精神疾病治疗方法的传播?
Am J Psychiatry. 2008 Nov;165(11):1385-92. doi: 10.1176/appi.ajp.2008.08030334.
5
Who are the new users of antipsychotic medications?抗精神病药物的新使用者有哪些?
Psychiatr Serv. 2008 May;59(5):507-14. doi: 10.1176/ps.2008.59.5.507.
6
Is managed care restraining the adoption of technology by hospitals?管理式医疗是否在抑制医院采用技术?
J Health Econ. 2008 Jul;27(4):1026-1045. doi: 10.1016/j.jhealeco.2008.02.009. Epub 2008 Mar 6.
7
Custom-made versus ready-to-wear treatments: behavioral propensities in physicians' choices.定制治疗与现成治疗:医生选择中的行为倾向
J Health Econ. 2007 Dec 1;26(6):1101-27. doi: 10.1016/j.jhealeco.2007.08.002. Epub 2007 Sep 6.
8
Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century.21世纪初美国心境障碍的患病率、共病情况及服务利用情况。
Annu Rev Clin Psychol. 2007;3:137-58. doi: 10.1146/annurev.clinpsy.3.022806.091444.
9
Mental health treatment expenditure trends, 1986-2003.1986 - 2003年心理健康治疗支出趋势
Psychiatr Serv. 2007 Aug;58(8):1041-8. doi: 10.1176/ps.2007.58.8.1041.
10
Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia.第二代抗精神病药物与奋乃静治疗慢性精神分裂症随机试验的成本效益
Am J Psychiatry. 2006 Dec;163(12):2080-9. doi: 10.1176/ajp.2006.163.12.2080.